Pure Health Holding PJSC (ADX: PUREHEALTH)

Pure Health Holding PJSC Cash Flow Statement

Financials in millions AED. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	617.01	964.66	3,718
Depreciation & Amortization	1,220	915.28	358.57
Other Amortization	49.3	49.3	21.56
Loss (Gain) From Sale of Assets	-3.95	0.61	19.11
Asset Writedown & Restructuring Costs	0.19	0.16	7.28
Loss (Gain) From Sale of Investments	25.12	8.71	-5.44
Loss (Gain) on Equity Investments	-76.77	-25.15	-0.32
Provision & Write-off of Bad Debts	180.3	155.03	10.18
Other Operating Activities	662.06	260.82	223.89
Change in Accounts Receivable	566.48	1,136	1,889
Change in Inventory	-243.71	-146.76	65.47
Change in Accounts Payable	-637.32	-956.06	-1,212
Change in Other Net Operating Assets	273.37	168.09	-910.39
Operating Cash Flow	2,637	2,531	4,186
Operating Cash Flow Growth	-37.01%	-39.54%	-
Capital Expenditures	-700.97	-390.47	-231.08
Sale of Property, Plant & Equipment	6.75	0.1	0.03
Cash Acquisitions	-2,686	44.76	5,556
Divestitures	-64.24	-1.49	-
Sale (Purchase) of Intangibles	-90.58	-58.55	-27.45
Investment in Securities	-423.13	-2,227	-1,638
Other Investing Activities	296.82	149.53	17.32
Investing Cash Flow	-3,659	-2,482	3,679
Short-Term Debt Repaid	-	-110.36	-
Long-Term Debt Repaid	-	-90.01	-39.65
Total Debt Repaid	-1,221	-200.37	-39.65
Net Debt Issued (Repaid)	608.99	-200.37	-39.65
Issuance of Common Stock	3,619	3,619	-
Common Dividends Paid	-	-300	-3,058
Other Financing Activities	-27.1	20.19	31.37
Financing Cash Flow	4,201	3,139	-3,066
Net Cash Flow	3,175	3,188	4,799
Free Cash Flow	1,936	2,141	3,955
Free Cash Flow Growth	-51.05%	-45.88%	-
Free Cash Flow Margin	9.33%	13.05%	31.68%
Free Cash Flow Per Share	0.18	0.21	0.40
Cash Interest Paid	84.55	38.25	18.84
Levered Free Cash Flow	-	-448.24	-
Unlevered Free Cash Flow	-	-374.82	-
Change in Net Working Capital	-	129.85	-

Source: S&P Capital IQ. Standard template. Financial Sources.